Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ALEC
ALEC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ALEC News
Alector Discontinues Mid-Stage Alzheimer’s Trial for Latozinemab
Apr 30 2026
seekingalpha
Middle East Stock Markets: Small-Cap Gems Analysis
Apr 28 2026
Yahoo Finance
Alector Upgraded to Overweight by Cantor Fitzgerald on BBB Technology Potential
Apr 15 2026
seekingalpha
Alector Shares Surge 15% After Upgrade to Buy by BRIG
Mar 10 2026
seekingalpha
Latest Wall Street Rating Updates
Mar 10 2026
CNBC
Wall Street Analysts Adjust Ratings
Mar 10 2026
Benzinga
Alector Showcases ABC Brain-Delivery Platform Progress
Mar 04 2026
Yahoo Finance
Alector Reports Q4 Earnings Amidst Challenges
Feb 26 2026
seekingalpha
Alector's Phase 3 Trial Results Fail to Meet Expectations
Jan 29 2026
PRnewswire
Alector Appoints Neil Berkley as CFO, Strengthening Leadership Amid Strategic Growth
Dec 12 2025
Globenewswire
Alector Appoints Neil Berkley as CFO to Drive Biotech Strategy
Dec 12 2025
Newsfilter
Alector Appoints Neil Berkley as CFO
Dec 12 2025
NASDAQ.COM
Alector Shares Plunge Nearly 50% Following Phase 3 Trial Failure
Nov 26 2025
Globenewswire
ALEC Investors Can Participate in Alector, Inc. Fraud Investigation Led by the Schall Law Firm
Nov 19 2025
Globenewswire
Significant Wednesday Options Trading: AI, BC, ALEC
Oct 22 2025
NASDAQ.COM
Alector's Dementia Program Stopped Due to Clinical Setback, Workforce Cutbacks Implemented
Oct 22 2025
Benzinga
Show More News
